Skip to content
Menu

Lakefront Biotherapeutics NV GLPGF

Full chart Compare
Set alert

Price alert · GLPGF

All alert types
35.15 USD 0.00 (+0.00%)

Regular-session close

35.15 Day range 35.15
26.24 52-week range 35.15
YTD
+12.34%
1 year
+5.08%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

21.95 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 5

Valuation

P/E 5.5×
P/S 1.6×
P/B 0.5×
P/FCF -8.3×
EV/EBITDA 3.2×
EV/Sales 1.5×
FCF Yield -12.0%

Profitability

Gross Margin 97.3%
Operating Margin 42.2%
Net Margin 28.9%
ROE 9.9%
ROIC 14.4%
ROA 9.4%

Growth (YoY)

Revenue 303.4%
Operating Income 349.3%
EPS (diluted) 334.8%
Free Cash Flow 47.6%

Financial Health

Current Ratio 20.1×
Quick Ratio 20.0×
Debt / Equity 0.0×
Net Debt / EBITDA -0.2×
Interest Coverage 212×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31